Citigroup »

Lantern Pharma shares owned by Citigroup

Quarter-by-quarter ownership of Lantern Pharma (LTRN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Lantern Pharma

Tip: Access up to 7 years of quarterly data

All positions including Lantern Pharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantern Pharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $62 45 1.38

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Lantern Pharma

BIOS Capital Management
Vanguard Group
Vanguard Capital Management
CM Management
Geode Capital Management
Renaissance Technologies
Westside Investment Management
Voss Capital
Vanguard Fiduciary Trust
BlackRock
Dimensional Fund Advisors
Susquehanna International
Horizon Kinetics Asset Management
Goss Wealth Management
Davenport & Co

View all funds holding Lantern Pharma